Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6. Hepcidin suppression allows for the mobilization of iron to the bone marrow for the production of red blood cells. Aberrantly high circulating ERFE in...
Hoofdauteurs: | Arezes, J, Foy, N, McHugh, K, Quinkert, D, Benard, S, Sawant, A, Frost, J, Armitage, A, Pasricha, S, Lim, P, Tam, M, Lavallie, E, Pittman, D, Cunningham, O, Lambert, M, Murphy, J, Draper, S, Jasuja, R, Drakesmith, A |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
American Society of Hematology
2020
|
Gelijkaardige items
-
Erythroferrone inhibits the induction of hepcidin by BMP6
door: Arezes, J, et al.
Gepubliceerd in: (2018) -
Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
door: Tsz Yuen Au, et al.
Gepubliceerd in: (2022-09-01) -
Regulation of hepcidin by erythropoiesis: The story so far.
door: Pasricha, S, et al.
Gepubliceerd in: (2016) -
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
door: Richard Coffey, et al.
Gepubliceerd in: (2018-04-01) -
Erythroferrone and hepcidin levels in children with iron deficiency anemia
door: Ramazan Dulkadir, et al.
Gepubliceerd in: (2024-04-01)